COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Stopped early · Phase 3 · Has a placebo group

Conditions studied: COVID-19

In brief

A multi-center adaptive randomized placebo-controlled platform trial evaluating the efficacy and safety of anti-thrombotic strategies in COVID-19 adults not requiring hospitalization at time of diagnosis

Key facts

Study ID
NCT04498273
Run by
Frank C Sciurba
People needed
657
Starts
2020-09-07
Expected to finish
2021-08-05
Last updated by the study team
2022-02-17

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.